Nuclease Probe Technologies Revenue

Medical Equipment Manufacturing • Lowell, Massachusetts, United States • 1-10 Employees

Nuclease Probe Technologies revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$547,552
Total funding	$500,000

Key Contact at Nuclease Probe Technologies

Paula Henry

Director

Company overview

Headquarters	110 Canal Street, 4th Floor, Lowell, MA 01852, US
Phone number	+115250016
Website	nptrapidtesting.com
NAICS	3391
SIC	873
Keywords	Veterinary, Proteins, Ph.D., Escherichia Coli, Microbial Identification, Antibiotic Susceptibility Testing, Bloodstream Infections, Culture Free, Staphylococcus Aureus, Enterobacteriaceae, Enterococcus, Klebsiella Pneumoniae, Microbial Resistance, Nucleases, Pseudomonas Aeruginosa, Rapid Sepsis Diagnostics, Skin And Soft Tissue Infections, James O. Mcnamara Ii, Pyoderma, Staphylococcus Pseudintermedius
Founded	2014
Employees	1-10
Socials

About Nuclease Probe Technologies

NPT uses a proprietary platform technology to produce next-generation rapid diagnostics for infectious diseases. This same technology can also determine key properties of microbial pathogens such as the antibiotic susceptibility profiles of bacteria. The rising rate of antibiotic resistance makes administration of antibiotics prior to determining antibiotic susceptibility increasingly problematic. Our first product, the NucAP Pyoderma Tri-plate, rapidly determines antibiotic susceptibilities of bacterial pathogens that cause canine skin infections, providing veterinarians with same-day actionable data. Simple quenched fluorescent oligonucleotides that are engineered to yield a fluorescent signal in the presence of target pathogens are at the heart of NPT’s technology. The platform interfaces a category of biomarkers known as nucleases that serve as signal-generating molecules.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Nuclease Probe Technologies's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-04-07	3	$500,000

Funding Insights

$500,000

Total funding amount

$500,000

Most recent funding amount

Number of funding rounds

Nuclease Probe Technologies Tech Stack

Discover the technologies and tools that power Nuclease Probe Technologies's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Apache HTTP Server

Web servers

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

GoDaddy

Hosting

cdnjs

CDN

Shipping carriers

Bootstrap

UI frameworks

Cart Functionality

Ecommerce

YouTube

Video players

Google Maps

Maps

Frequently asked questions

Nuclease Probe Technologies is located in Lowell, Massachusetts, US.

You can reach Nuclease Probe Technologies at +115250016.

Nuclease Probe Technologies generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Nuclease Probe Technologies has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Nuclease Probe Technologies was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Nuclease Probe Technologies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Nuclease Probe Technologies has raised a total of $500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Nuclease Probe Technologies

Paula Henry

Director

4.8

40,000 users